ChemoCentryx, Inc.
CCXI
CCXI was delisted on the 19th of October, 2022.
100 hedge funds and large institutions have $239M invested in ChemoCentryx, Inc. in 2019 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 31 increasing their positions, 34 reducing their positions, and 30 closing their positions.
19% more call options, than puts
Call options by funds: $5.26M | Put options by funds: $4.44M
9% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 34
15% less funds holding
Funds holding: 117 → 100 (-17)
31% less capital invested
Capital invested by funds: $346M → $239M (-$107M)
57% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 30
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$4.54M |
| 2 |
CG
Carmignac Gestion
Paris,
France
|
+$3.57M |
| 3 |
Millennium Management
New York
|
+$3.18M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.65M |
| 5 |
BlackRock
New York
|
+$1.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$12.5M |
| 2 |
State Street
Boston,
Massachusetts
|
-$7.84M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$4.09M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.86M |
| 5 |
3C
361 Capital
Denver,
Colorado
|
-$1.84M |
CCXI Hedge Fund Activity: Q3 2019 in Review
100 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q3 2019, worth a combined $239M — down 31% from $346M a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of CCXI and 13 opened new positions — a net loss of 17 holders — while 34 trimmed existing stakes and 31 added.
The largest buyer was UBS Group, adding an estimated $4.54M. The largest seller was Franklin Resources, exiting entirely with an estimated $12.5M sold.
- 100 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q3 2019, down from 117 in Q2 2019.
- Funds reported $239M of ChemoCentryx, Inc. stock for Q3 2019, down 31% quarter-over-quarter.
- 13 funds opened new ChemoCentryx, Inc. positions in Q3 2019 and 30 closed out, a net change of -17 holders.
- The largest ChemoCentryx, Inc. buyer in Q3 2019 was UBS Group, an estimated $4.54M added.
- The largest ChemoCentryx, Inc. seller in Q3 2019 was Franklin Resources, an estimated $12.5M sold.
Based on aggregated 13F filings for Q3 2019.